These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30246934)

  • 1. Molecular and Synaptic Bases of CDKL5 Disorder.
    Zhu YC; Xiong ZQ
    Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic loss of cyclin-dependent kinase-like 5 recapitulates methylphenidate-remediable hyperlocomotion in mouse model of CDKL5 deficiency disorder.
    Jhang CL; Lee HY; Chen JC; Liao W
    Hum Mol Genet; 2020 Aug; 29(14):2408-2419. PubMed ID: 32588892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons.
    Loi M; Trazzi S; Fuchs C; Galvani G; Medici G; Gennaccaro L; Tassinari M; Ciani E
    Mol Neurobiol; 2020 May; 57(5):2244-2262. PubMed ID: 32002787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1.
    Della Sala G; Putignano E; Chelini G; Melani R; Calcagno E; Michele Ratto G; Amendola E; Gross CT; Giustetto M; Pizzorusso T
    Biol Psychiatry; 2016 Aug; 80(4):302-311. PubMed ID: 26452614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
    Tramarin M; Rusconi L; Pizzamiglio L; Barbiero I; Peroni D; Scaramuzza L; Guilliams T; Cavalla D; Antonucci F; Kilstrup-Nielsen C
    Hum Mol Genet; 2018 Jun; 27(12):2052-2063. PubMed ID: 29618004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.
    Fuchs C; Gennaccaro L; Trazzi S; Bastianini S; Bettini S; Lo Martire V; Ren E; Medici G; Zoccoli G; Rimondini R; Ciani E
    Neural Plast; 2018; 2018():9726950. PubMed ID: 29977282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel CDKL5 targets identified in human iPSC-derived neurons.
    Massey S; Ang CS; Davidson NM; Quigley A; Rollo B; Harris AR; Kapsa RMI; Christodoulou J; Van Bergen NJ
    Cell Mol Life Sci; 2024 Aug; 81(1):347. PubMed ID: 39136782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.
    Katayama S; Sueyoshi N; Inazu T; Kameshita I
    Neural Plast; 2020; 2020():6970190. PubMed ID: 32587608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
    MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
    Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorder.
    Tang S; Terzic B; Wang IJ; Sarmiento N; Sizov K; Cui Y; Takano H; Marsh ED; Zhou Z; Coulter DA
    Nat Commun; 2019 Jun; 10(1):2655. PubMed ID: 31201320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
    Olson HE; Demarest ST; Pestana-Knight EM; Swanson LC; Iqbal S; Lal D; Leonard H; Cross JH; Devinsky O; Benke TA
    Pediatr Neurol; 2019 Aug; 97():18-25. PubMed ID: 30928302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures.
    Wang HT; Zhu ZA; Li YY; Lou SS; Yang G; Feng X; Xu W; Huang ZL; Cheng X; Xiong ZQ
    Epilepsia; 2021 Feb; 62(2):517-528. PubMed ID: 33400301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
    Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
    Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GABA
    Gennaccaro L; Fuchs C; Loi M; Roncacè V; Trazzi S; Ait-Bali Y; Galvani G; Berardi AC; Medici G; Tassinari M; Ren E; Rimondini R; Giustetto M; Aicardi G; Ciani E
    Neurobiol Dis; 2021 Jun; 153():105304. PubMed ID: 33621640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells.
    Valli E; Trazzi S; Fuchs C; Erriquez D; Bartesaghi R; Perini G; Ciani E
    Biochim Biophys Acta; 2012; 1819(11-12):1173-85. PubMed ID: 22921766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder.
    Trazzi S; Fuchs C; Viggiano R; De Franceschi M; Valli E; Jedynak P; Hansen FK; Perini G; Rimondini R; Kurz T; Bartesaghi R; Ciani E
    Hum Mol Genet; 2016 Sep; 25(18):3887-3907. PubMed ID: 27466189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping pathological phenotypes in a mouse model of CDKL5 disorder.
    Amendola E; Zhan Y; Mattucci C; Castroflorio E; Calcagno E; Fuchs C; Lonetti G; Silingardi D; Vyssotski AL; Farley D; Ciani E; Pizzorusso T; Giustetto M; Gross CT
    PLoS One; 2014; 9(5):e91613. PubMed ID: 24838000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder.
    Voronin G; Narasimhan J; Gittens J; Sheedy J; Lipari P; Peters M; DeMarco S; Cao L; Varganov Y; Kim MJ; Pear L; Fotouh E; Sinha S; Ray B; Wu MC; Yalamanchili P; Southgate C; Pick J; Saadipour K; Jung S; Lee J; Mollin A; Welch EM; Wu Z; Weetall M
    Mol Ther; 2024 Oct; 32(10):3331-3345. PubMed ID: 39033321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of cdkl5 during zebrafish early development: implications for use as model for atypical Rett syndrome.
    Vitorino M; Cunha N; Conceição N; Cancela ML
    Mol Biol Rep; 2018 Aug; 45(4):445-451. PubMed ID: 29752575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new consensus for evaluating CDKL5/STK9-dependent signalling mechanisms.
    Eyers PA
    EMBO J; 2018 Dec; 37(24):. PubMed ID: 30377159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.